Innoviva, Inc.

NasdaqGS:INVA Rapport sur les actions

Capitalisation boursière : US$1.1b

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Innoviva Croissance future

Future contrôle des critères 0/6

Innoviva devrait augmenter son chiffre d'affaires de 7.1% par an.

Informations clés

n/a

Taux de croissance des bénéfices

n/a

Taux de croissance du BPA

Pharmaceuticals croissance des bénéfices23.6%
Taux de croissance des recettes7.1%
Rendement futur des capitaux propresn/a
Couverture par les analystes

Low

Dernière mise à jour09 Aug 2024

Mises à jour récentes de la croissance future

Recent updates

Benign Growth For Innoviva, Inc. (NASDAQ:INVA) Underpins Its Share Price

Jul 26
Benign Growth For Innoviva, Inc. (NASDAQ:INVA) Underpins Its Share Price

Innoviva: Potentially Overvalued

Jun 21

Why Innoviva's (NASDAQ:INVA) Shaky Earnings Are Just The Beginning Of Its Problems

May 21
Why Innoviva's (NASDAQ:INVA) Shaky Earnings Are Just The Beginning Of Its Problems

Here's Why Innoviva (NASDAQ:INVA) Can Manage Its Debt Responsibly

Feb 05
Here's Why Innoviva (NASDAQ:INVA) Can Manage Its Debt Responsibly

Is Innoviva (NASDAQ:INVA) A Risky Investment?

Nov 04
Is Innoviva (NASDAQ:INVA) A Risky Investment?

Innoviva (NASDAQ:INVA) Seems To Use Debt Quite Sensibly

Mar 02
Innoviva (NASDAQ:INVA) Seems To Use Debt Quite Sensibly

Innoviva Stock? Not Yet. Short Puts? Definitely.

Sep 19

Does Innoviva (NASDAQ:INVA) Have A Healthy Balance Sheet?

Sep 19
Does Innoviva (NASDAQ:INVA) Have A Healthy Balance Sheet?

Does Innoviva (NASDAQ:INVA) Have A Healthy Balance Sheet?

Jun 16
Does Innoviva (NASDAQ:INVA) Have A Healthy Balance Sheet?

Continuing To Avoid Innoviva Inc.

Jun 07

We Think Innoviva (NASDAQ:INVA) Can Manage Its Debt With Ease

Mar 04
We Think Innoviva (NASDAQ:INVA) Can Manage Its Debt With Ease

Taking Innoviva Winnings Off The Table, Again

Feb 21

Innoviva Inc.: Short Puts Are Compelling

Jan 15

Is Innoviva (NASDAQ:INVA) A Risky Investment?

Oct 19
Is Innoviva (NASDAQ:INVA) A Risky Investment?

Taking Profits In Innoviva Inc.

Oct 16

Innoviva reports Q1 results

Apr 28

These 4 Measures Indicate That Innoviva (NASDAQ:INVA) Is Using Debt Safely

Mar 30
These 4 Measures Indicate That Innoviva (NASDAQ:INVA) Is Using Debt Safely

Is Weakness In Innoviva, Inc. (NASDAQ:INVA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Mar 04
Is Weakness In Innoviva, Inc. (NASDAQ:INVA) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Did Innoviva's (NASDAQ:INVA) Share Price Deserve to Gain 36%?

Jan 15
Did Innoviva's (NASDAQ:INVA) Share Price Deserve to Gain 36%?

These 4 Measures Indicate That Innoviva (NASDAQ:INVA) Is Using Debt Safely

Dec 25
These 4 Measures Indicate That Innoviva (NASDAQ:INVA) Is Using Debt Safely

Will Weakness in Innoviva, Inc.'s (NASDAQ:INVA) Stock Prove Temporary Given Strong Fundamentals?

Dec 04
Will Weakness in Innoviva, Inc.'s (NASDAQ:INVA) Stock Prove Temporary Given Strong Fundamentals?

Innoviva: Only For Short-Term Traders

Nov 04

Innoviva reports Q3 results

Oct 28

Prévisions de croissance des bénéfices et des revenus

NasdaqGS:INVA - Estimations futures des analystes et données financières antérieures (USD Millions )
DateRecettesLes revenusFlux de trésorerie disponibleCash from OpMoy. Nombre d'analystes
12/31/2026369N/A1231162
12/31/2025341N/A90932
12/31/2024339N/AN/A852
6/30/2024330145158158N/A
3/31/2024312181152152N/A
12/31/2023310180141141N/A
9/30/202329050116117N/A
6/30/20232902338888N/A
3/31/2023318233129129N/A
12/31/2022331214202202N/A
9/30/2022373293291291N/A
6/30/202240499372372N/A
3/31/2022396188378378N/A
12/31/2021392266364364N/A
9/30/2021375309351351N/A
6/30/2021365265329329N/A
3/31/2021344253324324N/A
12/31/2020337224313313N/A
9/30/2020322216295295N/A
6/30/2020299228278278N/A
3/31/2020285189254254N/A
12/31/2019261157257257N/A
9/30/2019265375252252N/A
6/30/2019261382255255N/A
3/31/2019264399250250N/A
12/31/2018261395224224N/A
9/30/2018251190210210N/A
6/30/2018238166193193N/A
3/31/2018229147N/A164N/A
12/31/2017217134N/A142N/A
9/30/2017191101N/A115N/A
6/30/201717692N/A92N/A
3/31/201715072N/A81N/A
12/31/201613460N/A61N/A
9/30/201611338N/A47N/A
6/30/20169319N/A29N/A
3/31/201671-4N/A19N/A
12/31/201554-19N/A10N/A
9/30/201538-39N/A-1N/A
6/30/201526-56N/A-25N/A
3/31/201516-68N/A-82N/A
12/31/20148-74N/A-131N/A
9/30/20143-66N/A-166N/A
6/30/20142-55N/A-186N/A
3/31/20142-9N/A-149N/A
12/31/20135-31N/A-130N/A
9/30/20139-53N/A-114N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: Données insuffisantes pour déterminer si la croissance des bénéfices prévue de INVA est supérieure au taux d'épargne ( 2.5% ).

Bénéfices vs marché: Données insuffisantes pour déterminer si les bénéfices de INVA devraient croître plus rapidement que le marché US

Croissance élevée des bénéfices: Données insuffisantes pour déterminer si les bénéfices de INVA devraient augmenter de manière significative au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de INVA ( 7.1% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de INVA ( 7.1% par an) devrait croître plus lentement que 20% par an.


Prévisions de croissance du bénéfice par action


Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de INVA devrait être élevé dans 3 ans


Découvrir les entreprises en croissance